 Blood Coagulation Factors
"Blood Coagulation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, that are involved in the blood coagulation process.
| Descriptor ID |
D001779
|
| MeSH Number(s) |
D12.776.124.125 D23.119
|
| Concept/Terms |
Blood Coagulation Factors- Blood Coagulation Factors
- Blood Coagulation Factor
- Factor, Blood Coagulation
- Coagulation Factor, Blood
- Coagulation Factors, Blood
- Factors, Blood Coagulation
- Coagulation Factors
- Factor, Coagulation
- Factors, Coagulation
- Coagulation Factor
- Clotting Factors
- Factors, Clotting
|
Below are MeSH descriptors whose meaning is more general than "Blood Coagulation Factors".
Below are MeSH descriptors whose meaning is more specific than "Blood Coagulation Factors".
This graph shows the total number of publications written about "Blood Coagulation Factors" by people in this website by year, and whether "Blood Coagulation Factors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 2001 | 1 | 1 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 2 | 3 | | 2006 | 1 | 3 | 4 | | 2007 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 1 | 1 | 2 | | 2014 | 2 | 2 | 4 | | 2015 | 1 | 1 | 2 | | 2016 | 4 | 1 | 5 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 2 | 1 | 3 | | 2020 | 4 | 2 | 6 | | 2021 | 2 | 2 | 4 | | 2022 | 0 | 3 | 3 | | 2023 | 1 | 1 | 2 | | 2024 | 1 | 0 | 1 | | 2025 | 3 | 0 | 3 | | 2026 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Coagulation Factors" by people in Profiles.
-
Cotiguala L, Przybylski A, Linberger L, Brokhof M, Kenyon N, Joyce C, Dierker M, Ferguson K, Rech MA, Trotter C, Aguirre O, Lopez-Soler RI. Apixaban Use Before Kidney Transplantation: Is Reversal Necessary? Pharmacotherapy. 2026 Oct; 46(10):e70200.
-
Houska N, McCaw N, Meneses EC, Ing RJ, Whitney G, Fraser C, Warren BB, Navaratnam M, Kim JS. Thrombotic Outcomes Associated With Factor Eight Inhibitor Bypassing Activity Use in Neonatal and Infant Cardiac Surgery Including the Norwood Procedure: A Propensity Score?Matched Analysis. J Cardiothorac Vasc Anesth. 2026 Sep; 40(9):2681-2691.
-
Redden SC, Sun DJ, Wang YW, Hartwell E, Cardenas JC, Olson SD, Cotton BA. An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product. Transfusion. 2026 May; 66 Suppl 1:S172-S177.
-
Valle MM, Robledo A, O'Leary S, Basurto L, Reyes-Maldonado E, Gaspar J, Rosales E, Vega-Garcia S, MartÃnez-Murillo C. Cardiovascular risk factors associated with BMI and metabolic health phenotypes based on measures of coagulation factors. Int J Obes (Lond). 2025 12; 49(12):2530-2537.
-
Markovic N, Budde E, Evans CT, Finch D, Xia Y, Huo Z, Han JH, Rech MA. Time to hemostatic agent administration increases mortality in veterans with factor Xa inhibitor-related intracranial hemorrhage. Am J Emerg Med. 2025 12; 98:201-206.
-
Rech MA, Budde E, Evans CT, Finch D, Xia Y, Huo Z, Han JH. Andexanet alfa increases 30-day thrombotic events relative to four-factor prothrombin complex concentrate for factor Xa inhibitors-related intracerebral hemorrhage in veterans. Am J Emerg Med. 2025 11; 97:97-102.
-
Rosenthal CA, Douin DJ, Cohen MJ, Rizzo JA, April MD, Schauer SG. Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry. Transfus Med. 2024 Dec; 34(6):520-526.
-
Mazzeffi M, Beller J, Strobel R, Norman A, Wisniewski A, Smith J, Fonner CE, McNeil J, Speir A, Singh R, Tang D, Quader M, Yarboro L, Teman N. Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia. J Cardiothorac Vasc Anesth. 2024 03; 38(3):660-666.
-
Rech MA, Gottlieb M. Prothrombin Complex Concentrate Should Be Used to Reverse Factor Xa Inhibitors in the Setting of Life-Threatening Bleeding. Ann Emerg Med. 2023 09; 82(3):362-363.
-
Waberski AT, Busack C, d'Acoz YD, Matisoff AJ. Massive Clot Formation Following FEIBA and Tranexamic Acid Administration in Postcardiopulmonary Bypass Hemorrhage. J Cardiothorac Vasc Anesth. 2022 10; 36(10):3863-3866.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|